Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people wi...

 Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are pleased to a...

 iProcess Global Research Inc. today announced the launch of AxisOne (axisone.ai), an AI-powered platform the company calls the R&D operating system for the worl...

Axithra today announced the appointment of Lars Kongsbak as Chief Executive Officer. With over 25 years of industry leadership, Kongsbak will lead the company throug...

Strengthening its clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets The START Center for Cancer R...

AddParts, a UK-based technology company enabling pharmaceutical manufacturers to improve production continuity and reduce operational risk, has secured a six-figure ...

Takara Bio and Resistomap Oy today announce a strategic agreement to deepen their partnership in developing streamlined end-to-end solutions for high throughput anti...

Ofichem has brought its brands - Ofichem BV, Ofipharma, Ofimedicine, Labatorium Ofichem, Ofichem Uppsala, and Avivia - together as one family-owned CDMO and pharmace...

Dr. Al Mutar brings deep expertise in gastrointestinal oncology and early-phase clinical trials and will help to expand access to innovative therapies across North T...

he Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has inaugurated the Abu Dhabi Biobank, an integrated platform devel...